- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.68 Å
- Oligo State
- monomer
- Ligands
- 1 x 9NX: 5-bromanyl-2-methoxy-4-[(E)-(3-methylsulfanyl-5-phenyl-1,2,4-triazol-4-yl)iminomethyl]phenol(Non-covalent)
- 1 x NA: SODIUM ION(Non-functional Binders)
- 26 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.3: 10 residues within 4Å:- Chain A: Q.41, Y.44, L.46, V.72, I.74, V.106, D.108, A.115
- Ligands: NA.2, EDO.6
Ligand excluded by PLIPEDO.4: 6 residues within 4Å:- Chain A: Q.41, D.42, Y.44, I.64
- Ligands: NA.2, EDO.5
Ligand excluded by PLIPEDO.5: 3 residues within 4Å:- Chain A: Q.41, D.42
- Ligands: EDO.4
Ligand excluded by PLIPEDO.6: 6 residues within 4Å:- Chain A: L.46, I.74, D.108, P.109, V.110
- Ligands: EDO.3
Ligand excluded by PLIPEDO.7: 7 residues within 4Å:- Chain A: G.95, G.96, P.97, N.98, I.99, R.177
- Ligands: EDO.15
Ligand excluded by PLIPEDO.8: 5 residues within 4Å:- Chain A: K.234, F.237, F.238, V.253, F.289
Ligand excluded by PLIPEDO.9: 5 residues within 4Å:- Chain A: Y.55, L.75, K.82, I.83, E.86
Ligand excluded by PLIPEDO.10: 8 residues within 4Å:- Chain A: N.123, T.124, P.164, V.167, M.168, I.169
- Ligands: EDO.18, EDO.19
Ligand excluded by PLIPEDO.11: 5 residues within 4Å:- Chain A: N.122, T.124, D.170, H.171, E.172
Ligand excluded by PLIPEDO.12: 6 residues within 4Å:- Chain A: P.9, E.192, D.210, Y.211, Q.212, M.213
Ligand excluded by PLIPEDO.13: 5 residues within 4Å:- Chain A: G.39, N.40, Q.41, V.106, K.107
Ligand excluded by PLIPEDO.14: 7 residues within 4Å:- Chain A: N.98, E.144, R.174, K.175, L.176, R.177
- Ligands: EDO.15
Ligand excluded by PLIPEDO.15: 6 residues within 4Å:- Chain A: P.97, N.98, E.144, K.147
- Ligands: EDO.7, EDO.14
Ligand excluded by PLIPEDO.16: 4 residues within 4Å:- Chain A: Y.130, R.233, K.234, E.235
Ligand excluded by PLIPEDO.17: 2 residues within 4Å:- Chain A: H.239, H.241
Ligand excluded by PLIPEDO.18: 5 residues within 4Å:- Chain A: P.164, V.167, M.226, M.230
- Ligands: EDO.10
Ligand excluded by PLIPEDO.19: 7 residues within 4Å:- Chain A: N.123, P.164, H.165, V.167, M.168
- Ligands: 9NX.1, EDO.10
Ligand excluded by PLIPEDO.20: 6 residues within 4Å:- Chain A: G.53, K.54, Y.55, S.56, D.180
- Ligands: 9NX.1
Ligand excluded by PLIPEDO.21: 6 residues within 4Å:- Chain A: D.161, K.163, L.183, A.198, S.199
- Ligands: EDO.23
Ligand excluded by PLIPEDO.22: 2 residues within 4Å:- Chain A: S.199, R.200
Ligand excluded by PLIPEDO.23: 5 residues within 4Å:- Chain A: R.196, V.197, A.198, K.203
- Ligands: EDO.21
Ligand excluded by PLIPEDO.24: 6 residues within 4Å:- Chain A: V.253, L.254, R.283, K.284, W.286, D.307
Ligand excluded by PLIPEDO.25: 7 residues within 4Å:- Chain A: L.50, E.60, H.120, V.121, N.122, N.123
- Ligands: 9NX.1
Ligand excluded by PLIPEDO.26: 1 residues within 4Å:- Ligands: EDO.27
Ligand excluded by PLIPEDO.27: 6 residues within 4Å:- Chain A: P.300, E.301, D.304, H.326, P.327
- Ligands: EDO.26
Ligand excluded by PLIPEDO.28: 2 residues within 4Å:- Chain A: L.208, N.243
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Oshima, T. et al., Cell-based screen identifies a new potent and highly selective CK2 inhibitor for modulation of circadian rhythms and cancer cell growth. Sci Adv (2019)
- Release Date
- 2019-03-06
- Peptides
- Casein kinase II subunit alpha: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.68 Å
- Oligo State
- monomer
- Ligands
- 1 x 9NX: 5-bromanyl-2-methoxy-4-[(E)-(3-methylsulfanyl-5-phenyl-1,2,4-triazol-4-yl)iminomethyl]phenol(Non-covalent)
- 1 x NA: SODIUM ION(Non-functional Binders)
- 26 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Oshima, T. et al., Cell-based screen identifies a new potent and highly selective CK2 inhibitor for modulation of circadian rhythms and cancer cell growth. Sci Adv (2019)
- Release Date
- 2019-03-06
- Peptides
- Casein kinase II subunit alpha: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A